United States Antimony Corp 8-K Filing

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value UAMY NYSE American Common

Filing Documents

• tm2531385d1_8k.htm (8-K) — 29KB
• tm2531385d1_ex99-1.htm (EX-99.1) — 101KB
• tm2531385d1_ex99-1img001.jpg (GRAPHIC) — 2KB
• 0001104659-25-112528.txt ( ) — 367KB
• uamy-20251112.xsd (EX-101.SCH) — 4KB
• uamy-20251112_def.xml (EX-101.DEF) — 26KB
• uamy-20251112_lab.xml (EX-101.LAB) — 36KB
• uamy-20251112_pre.xml (EX-101.PRE) — 25KB
• tm2531385d1_8k_htm.xml (XML) — 5KB

02 Results of Operations and Financial

Item 2.02 Results of Operations and Financial Condition. On November 12, 2025, United States Antimony Corporation ("USAC", "US Antimony," or the "Company") held a conference call to discuss the Company's financial and operational results for the third quarter and nine months ended September 30, 2025. A recorded replay of the presentation is available on the Company's website at https://www.usantimony.com/investors until November 26, 2025. A written transcript of this conference call is being furnished by the Company on this Current Report as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 2.02 disclosure. The information in Item 2.02, including Exhibit 99.1, of this Current Report on Form 8-K is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. The information in Item 2.02, including Exhibit 99.1, of this Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. For a discussion of these risks, please refer to the Company's filings with the Securities and Exchange Commission. The Company disclaims any obligation to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as required by law.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Transcript of United States Antimony Corporation Conference Call on Third Quarter and Nine Months Ended September 30, 2025 Financial and Operational Results 104 Cover Page Interactive Data File (embedded with the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. UNITED STATES ANTIMONY CORPORATION Dated: November 14, 2025 By: /s/ Richard R. Isaak Richard R. Isaak SVP and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR